DCM
COCH icon

Difesa Capital Management’s Envoy Medical COCH Stock Holding History

Difesa Capital Management’s Portfolio COCH Stock Details COCH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-313,911
Closed -$3.15M – 211
2022
Q4 		$3.15M Hold
313,911
– – 2.44% 7
2022
Q3 		$3.09M Buy
+313,911
New +$3.08M 1.57% 8

Other funds holding COCH

AMC
Atlas Merchant Capital New York $789K AUM 60.67% 1-Year Est. Return
SIM
Sandia Investment Management Boston, Massachusetts $40.1M AUM 14.58% 1-Year Est. Return
MC
Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
KPF
K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Difesa Capital Management's COCH Position: Q1 2023 in Review

Difesa Capital Management sold out of Envoy Medical (COCH) in Q1 2023, closing a stake of 313,911 shares — an estimated $3.15M sold.

Difesa Capital Management first reported a position in COCH in Q3 2022 and held it in 2 quarters. The position peaked at $3.15M in Q4 2022. 24 funds tracked by Wall St. Rank hold COCH as of Q1 2023.

  • Difesa Capital Management reported no remaining Envoy Medical position as of Q1 2023 after selling out during the quarter.
  • Difesa Capital Management sold 313,911 Envoy Medical shares in Q1 2023, an estimated $3.15M.
  • Difesa Capital Management first reported a position in Envoy Medical in Q3 2022 and held it in 2 quarters.
  • Difesa Capital Management's Envoy Medical position peaked at $3.15M in Q4 2022.
  • 24 funds tracked by Wall St. Rank held Envoy Medical as of Q1 2023.

Based on Difesa Capital Management's 13F filing for Q1 2023, filed 15 May 2023.